Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Author Correction: A purine scaffold Hsp90 inhibitor destabilizes BCL-6 and has specific antitumor activity in BCL-6–dependent B cell lymphomas
Nature Medicine ( IF 82.9 ) Pub Date : 2024-04-03 , DOI: 10.1038/s41591-024-02957-0 Leandro. C Cerchietti , Eloisi. C Lopes , Shao. Ning Yang , Katerina Hatzi , Karen. L Bunting , Lucas. A Tsikitas , Alka Mallik , Ana. I Robles , Jennifer Walling , Lyuba Varticovski , Rita Shaknovich , Kapil. N Bhalla , Gabriela Chiosis , Ari Melnick
中文翻译：
作者更正：嘌呤支架 Hsp90 抑制剂会破坏 BCL-6 的稳定性，并在 BCL-6 依赖性 B 细胞淋巴瘤中具有特异性抗肿瘤活性
更新日期：2024-04-05
Nature Medicine ( IF 82.9 ) Pub Date : 2024-04-03 , DOI: 10.1038/s41591-024-02957-0 Leandro. C Cerchietti , Eloisi. C Lopes , Shao. Ning Yang , Katerina Hatzi , Karen. L Bunting , Lucas. A Tsikitas , Alka Mallik , Ana. I Robles , Jennifer Walling , Lyuba Varticovski , Rita Shaknovich , Kapil. N Bhalla , Gabriela Chiosis , Ari Melnick
中文翻译：
作者更正：嘌呤支架 Hsp90 抑制剂会破坏 BCL-6 的稳定性，并在 BCL-6 依赖性 B 细胞淋巴瘤中具有特异性抗肿瘤活性
京公网安备 11010802027423号